Galectin-3, new potential therapeutic target for cardiac remodelling
- PMID: 23537546
- DOI: 10.1093/eurjhf/hft055
Galectin-3, new potential therapeutic target for cardiac remodelling
Comment on
-
Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT.Eur J Heart Fail. 2013 May;15(5):511-8. doi: 10.1093/eurjhf/hfs205. Epub 2013 Jan 4. Eur J Heart Fail. 2013. PMID: 23291728 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical